1. The role of molecular imaging in precision radiation therapy for target definition, treatment planning optimisation and quality control

   • Giovanni Lucignani
   • Barbara A. Jereczek-Fossa
   • Roberto Orecchia

   Editorial 30 March 2004 Pages: 1059 - 1063

2. Comparison of ¹¹C-choline PET and FDG PET for the differential diagnosis of malignant tumors

   • Mei Tian
   • Hong Zhang
   • Keigo Endo

   Original Article 11 March 2004 Pages: 1064 - 1072

   

3. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET

   • Shu-Hang Ng
   • Joseph Tung-Chieh Chang
   • Tzu-Chen Yen

   Original Article 09 March 2004 Pages: 1073 - 1080

   

4. MicroPET imaging of brain tumor angiogenesis with ¹⁸F-labeled PEGylated RGD peptide

   • Xiaoyuan Chen
   • Ryan Park
   • Peter S. Conti

   Original Article 29 April 2004 Pages: 1081 - 1089

   

5. Radiolabelling of glycosylated MFE-23::CPG2 fusion protein (MFECP1) with ^99mTc for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT)

   • R. J. Francis
   • S. J. Mather
   • R. H. J. Begent

   Original Article 17 March 2004 Pages: 1090 - 1096

   

6. ⁶⁸Ga-labelled DOTA-derivatised peptide ligands

   • G.-J. Meyer
   • H. Mäcke
   • M. Hofmann

   Original Article 17 March 2004 Pages: 1097 - 1104

   

7. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT

   • Rachel Bar-Shalom
   • Diana Gaitini
   • Ora Israel

   Original Article 09 March 2004 Pages: 1105 - 1113

   

8. A new model for separation between brain dopamine and serotonin transporters in ¹²³I-β-CIT SPECT measurements: normal values and sex and age dependence

   • Erik Ryding
   • Mats Lindström
   • Ingmar Rosén

   Original Article 11 March 2004 Pages: 1114 - 1118

   

9. Dopamine transporter SPECT using fast kinetic ligands: ¹²³I-FP-β-CIT versus ^99mTc-TRODAT-1

   • K. Van Laere
   • L. De Ceuninck
   • L. Mortelmans

   Original Article 03 April 2004 Pages: 1119 - 1127

   

10. The dopamine D₂ receptor ligand ¹⁸F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism

    • Mathias Schreckenberger
    • Stefan Hägele
    • Thomas Vogt

    Original Article 23 March 2004 Pages: 1128 - 1135

    

11. Characterization of IMPY as a potential imaging agent for β-amyloid plaques in double transgenic PSAPP mice

    • Mei-Ping Kung
    • Catherine Hou
    • Hank F. Kung

    Original Article 09 March 2004 Pages: 1136 - 1145

    

12. Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT

    • Natascha Döbert
    • Martina Britten
    • Frank Grünwald

    Original Article 03 April 2004 Pages: 1146 - 1151

    

13. Scatter and attenuation correction changes interpretation of gated myocardial perfusion imaging

    • Allan Johansen
    • Peter Grupe
    • Poul Flemming Høilund-Carlsen

    Original Article 29 April 2004 Pages: 1152 - 1159

    

14. Quantitative cholescintigraphy and bile abnormalities in patients with acalculous biliary pain

    • Julio Ponce
    • Vicente Pons
    • Virginia Pertejo

    Original Article 17 March 2004 Pages: 1160 - 1165

15. A new reconstruction strategy for image improvement in pinhole SPECT

    • Tsutomu Zeniya
    • Hiroshi Watabe
    • Hidehiro Iida

    Original Article 17 March 2004 Pages: 1166 - 1172

    

16. Monte Carlo-based down-scatter correction of SPECT attenuation maps

    • Tomislav Bokulić
    • Brendan Vastenhouw
    • Freek J. Beekman

    Original Article 18 March 2004 Pages: 1173 - 1181

    

17. Fluorinated tracers for imaging cancer with positron emission tomography

    • Olivier Couturier
    • André Luxen
    • Roland Hustinx

    Review Article 06 July 2004 Pages: 1182 - 1206

    

18. Source of impaired image quality in 3D whole-body FDG PET scanning

    • Anne M. J. Paans
    • Sabine M. M. Boerdijk
    • Jan Pruim

    Letter to the Editor 10 June 2004 Pages: 1207 - 1207

19. Reply

    • H. Everaert
    • C. Vanhove

    10 June 2004 Pages: 1208 - 1208

20. Imaging techniques in the assessment of myocardial hibernation

    • Stephen Richard Underwood

    Letter to the Editor 10 June 2004 Pages: 1209 - 1209

21. Reply

    • Sally F. Barrington
    • J. Chambers
    • T. O. Nunan

    Letter to the Editor 10 June 2004 Pages: 1210 - 1211

22. Myocardial gated SPECT phantom

    • Boguslaw Stefaniak
    • Witold Cholewinski
    • Anna Tarkowska

    Letter to the Editor 19 May 2004 Pages: 1212 - 1213

23. Reply

    • Hein J. Verberne
    • Berthe L. F. van Eck-Smit
    • Joris E. N. Jaspers

    Letters to the Editor 19 May 2004 Pages: 1214 - 1214

24. A realistic 3-D gated cardiac phantom for quality control of gated myocardial perfusion SPET: the Amsterdam gated (AGATE) cardiac phantom

    • Jacco J. N. Visser
    • Ellinor Busemann Sokole
    • Berthe L. F. van Eck-Smit

    Erratum 08 July 2004 Pages: 1215 - 1216

    

25. The role of molecular imaging in precision radiation therapy for target definition, treatment planning optimisation and quality control

    • Giovanni Lucignani
    • Barbara A. Jereczek-Fossa
    • Roberto Orecchia

    Erratum 05 May 2004 Pages: 1217 - 1217

26. Usefulness of ¹⁸FDG/¹³N-ammonia PET imaging for evaluation of the cardiac damage in Churg-Strauss syndrome

    • Hiroyuki Morita
    • Ikuo Yokoyama
    • Ryozo Nagai

    Image of the Month 19 May 2004 Pages: 1218 - 1218